This study aimed to describe the disparities in immunization coverage between National Immunization Program (NIP) vaccines and non-NIP vaccines in Yiwu and to identify potential determinants. A face-to-face interview-based questionnaire survey among 423 migrant children born from 1 June 2010 to 31 May 2013 was conducted. Immunization coverage was estimated according to the vaccines scheduled at different age, the birth cohorts, and socio-demographic characteristics. Single-level logistic regression analysis was applied to identify the determinants of coverage of non-NIP vaccines. We found that NIP vaccines recorded higher immunization coverage compared with non-NIP vaccines (87.9100%-vs 0%-74.8%). Among the non-NIP vaccines, varicella vaccine (VarV) recorded the highest coverage of 85.4%, which was introduced in 1998; while 7-valent pneumococcal conjugate vaccine(PCV7) recorded the lowest coverage of 0% for primary series, which was introduced recently. Lower coverage rate of non-NIP vaccines was significantly associated with more siblings in household, shorter duration of living in the surveyed areas, lower family income, mother with a job, mother with poor awareness of vaccination, and mother with lower education level. We found the immunization coverage rate of non-NIP vaccines was significant lower than that of NIP vaccines. Expansion of NIP to include non-NIP vaccines can provide better protection against the vaccine preventable diseases through increased immunization coverage.
Introduction
Vaccination is one of the most successful strategies available for the prevention of infection diseases. 1, 2 Through the wide application of vaccines, the public health achievements included the eradication of smallpox and remarkable decrease in the morbidity and mortality of vaccine preventable diseases(VPDs) such as poliomyelitis, measles and hepatitis B. 3 Many countries have established a national immunization program (NIP) to organize public health leadership on immunization practice and to give technical and financial support for vaccination recommendations.
The China's NIP was established in 1978 and provided efforts to accommodate the demands of children at risk of VPDs. Since 2008, the Minister of Health(MoH, predecessor of National Health and Family Planning Committee) of China issued the vaccination schedule of NIP vaccines, which stipulats all children under 7 y of age should get following vaccines: Bacille CalmetteGu erin (BCG), hepatitis B vaccine (Hep B), diphtheria-tetanuspertussis vaccine (DTP), oral poliovirus vaccine (OPV), measles containing vaccine (MCV), Japanese encephalitis vaccine (JEV), meningococcal polysaccharide vaccine type a(MPV-a), meningococcal polysaccharide vaccine type a and c(MPV-ac), hepatitis A vaccine (Hep A), diphtheria-tetanus vaccine(DT) 4 The budget for NIP vaccines is covered by Chinese central government and these NIP vaccines are provided to all children(including migrant children) free of charge, without any extra service fee. All children can get all the NIP and non-NIP vaccination in any immunization clinics when they traveled to other areas. The sustain improvement of accessibility and service quality of immunization clinic has resulted in an optimal increase in overall immunization coverage for most of areas in China in recent years.
Additionally, through supplementary immunization activities (SIAs) for OPV and MCV, the incidence of relevant VPDs remained at all-time low. 7, 8 Despite these achievements, limited health financing restricted the China's NIP from expanding other vaccines. Many vaccines such as inactive poliovirus vaccine (IPV), varicella vaccine (VarV), Haemophilus influenzae type b vaccine(Hib), oral rotavirus vaccine(ORV), 7-valent pneumococcal conjugate vaccine (PCV7) have not been included in NIP. These non-NIP vaccines are paid by caregivers' out-of-pocket expense, therefore, the vaccination fee may become a barrier to vaccinate children who live in a poorer resource environment, especially for the migrant children. Similar to other countries, 9 increasing population mobility coupled with lower vaccination coverage of migrants has been identified as one of the key contributors to VPDs outbreaks like varicella or pneumococcal pneumonia. Furthermore, the coverage rates of non-NIP vaccines for migrant children were lower than those for resident children. The main reasons for that may include the poor living condition and the poor awareness of immunization for migrant people. Recently, the consensus that the support for non-NIP vaccines has not been reached but the presence of inequalities of public health has been increasingly recognized. [10] [11] [12] The difference of immunization coverage between NIP and non-NIP vaccines among migrant children should be evaluated to provide evidence for the Chinese NIP policy decision in future. However, data on the coverage difference between NIP and non-NIP vaccines among migrant children have been scarcely reported.
In this face to face interview based survey, we aimed to identify and describe the difference in coverage between NIP and non-NIP vaccines among migrant children in Yiwu and to address the challenges facing current NIP policy.
Results
Demographic characteristics of children and their family A total of 423 eligible children were interviewed and the immunization record booklets for all the surveyed children were available at the time of the interview. Of which 52% were male and 9.5% were preterm born. Almost 40% of the surveyed children were the only child in their family, and 63.8% were breast milk-fed. Twenty-five.3% of the surveyed children were attending the day-care center and 53.0% lived in Yiwu city for more than 6 months. More than half of the surveyed mothers were more than 30 y of age and 63.6% of them received junior middle school or less. Of all the surveyed mothers, 62.9% were housewives and only 38.3% of their family earned more than 500$(the exchange rate of RMB vs. $ is almost 6:1) per month. 70.4% of the surveyed mothers had a positive awareness of vaccination and 81.1% of them were satisfied with the immunization service they received ( Table 1) .
Overall immunization coverage
The immunization coverage rates for NIP and non-NIP vaccines were presented in Table 2 . In general, all NIP vaccines showed higher coverage rates compared with the non-NIP vaccines. The coverage rates of vaccines scheduled at 12 m were 98.1100%-for NIP vaccines while 0%-27.7% for non-NIP vaccines. The coverage rates of vaccines scheduled at 24 m were 93.9%-96.3% for NIP vaccines while 0%-74.8% for non-NIP vaccines. The coverage rates of vaccines scheduled at 36 m were 87.9% for NIP vaccines while 4.5% for non-NIP vaccines. For NIP vaccines, the coverage rates of vaccines scheduled at 24 m were lower than that of vaccines scheduled at 12 m (93.9%-96.3% vs 98.1%-100.0%). However, the coverage rates of non-NIP vaccines scheduled at 24 m were higher than that of vaccines scheduled at 12 m (0%-74.8% vs 0%-27.7%). Among non-NIP vaccines, the VarV recorded the highest coverage of 74.8%, while the PCV7 record the lowest coverage of 0% for both primary doses ( 3 doses) and boost dose ( 4 dose).
Coverage of primary series vaccination across birth cohorts Among all 3 birth cohorts (born from 1 June 2010 to 31 May 2013), the primary series immunization coverage rates were higher for the NIP vaccines than that for the non-NIP vaccines (Fig. 1, N=423) . The immunization coverage rates of BCG and MCV remained at 100% across all 3 birth cohorts, while the coverage for Hep B, OPV, DTP, JEV decreased slightly from 100% for 2010 birth cohort to 99.0%, 98.6%, 96.7%, 96.7% for 2012 birth cohort, respectively. The immunization coverage for ORV primary series was lowest in 2010 birth cohort by 24.2%, and highest in 2012 cohort with 30.6%. Although coverage of ORV remained relatively higher than that of Hib across all 3 cohorts, the coverage was still lower than that of NIP vaccines. The coverage for Hib fluctuated across all birth cohorts and tended to decrease slightly over the years.
Determinants associated with coverage of non-NIP vaccines
We found born status, siblings, duration of living in surveyed areas, family income per month were associated with the coverage of Hib in the uni-variate analysis(P < 0.1) and these 4 determinants were included in the logistic regression analysis for uptake of Hib. Similarly, 6 determinants including siblings, duration of living in surveyed areas, mother's age, mother's occupation status, family income per month, mother' s awareness of importance of vaccination were included in the logistic regression analysis for uptake of ORV as those variables with a P < 0.1 in the univariate analysis. Nine determinants including born status, siblings, breast milk feeding, duration of living in surveyed areas, mother's age, mother's education level, mother's occupation status, family income per month, mother' s awareness of importance of vaccination were included in the logistic regression analysis for uptake of VarV as those variables with a P < 0.1 in the univariate analysis ( Table 3) .
The socio-demographic determinants associated with the coverage of 3 non-NIP vaccines(Hib, ORV, VarV) in the single-level logistic regression analysis were presented inTable 3. The risk factors significantly associated with a lower coverage of Hib for migrant children were more siblings in the family, shorter duration of living in the surveyed areas and lower family income per month. The risk factors significantly associated with a lower coverage of ORV for migrant children were more siblings, shorter duration of living in the surveyed areas, child with working mother, lower family income per month, and mother with a negative awareness of vaccination. The risk factors significantly www.taylorandfrancis.comassociated with a lower coverage of VarV for migrant children were more siblings, shorter duration of living in the surveyed areas, mother with a lower education level, lower family income per month, as well as mother with a negative awareness of vaccination.
Discussion
The face-to-face interview survey of 423 children comparing coverage rates between NIP and non-NIP vaccines implicated that the immunization coverage rates of non-NIP vaccines were significantly lower than that of NIP vaccines in Yiwu. The coverage for NIP vaccines ranged between 87.9% and 100.0%, while the coverage for non-NIP vaccines ranged between 0% between 74.8%. Our observation agreed with previous reports from US 13 and Switzerland 14 that showed the lower immunization coverage for newly introduced vaccines compared to the traditionally recommended vaccines. The main reason for that in US was the shortage of vaccines, which might had affected accessibility to these new vaccines. These shortages affected children and healthcare providers. For example, if vaccine was unavailable at an immunization clinic visit, another visit could have been made at a later time when vaccine was available. Furthermore, according Significantly lower or higher coverage than the comparing group in the univariate analysis(P < 0.1) and the crude OR presented; { Significantly lower or higher coverage than the comparing group in the single-level logistic regression analysis(P < 0.05) and the adjust OR presented; CI:
confidence interval; COR: crude odds ratio; AOR: adjusted odds ratio; N.A.:not significant in the univariate analysis.
to our previous study, the public perception and training of immunization staff require additional time since newly developed vaccines are introduced in the market. Besides, the limited existing public health resources would also restrict the utilization of the vaccine. 15 This delay in widely application of the vaccine would be accelerated by the inclusion of the vaccine into NIP. However, the expansion of NIP is limited not only in lower socio-economic developing areas but also in developed areas like Yiwu. The reasons for this lag are multi-factorial, but political commitment is crucial.
Although challenges in funding limited the impetus for expansion of NIP, rapid increase in coverage of NIP vaccines among migrant children had been made in recent years in Yiwu. It may be due to the intervention since 2009: first, financial reimbursements by local government to providers with a 5 CNY per doses for each child (including migrant child); second, vaccination training program toward the immunization staff; third, continuous improvement program on the accessibility and service quality of immunization clinics in Yiwu. By implementing the package of interventions, an increase in coverage for NIP vaccines was expected. Coverage of 98.1100%-for primary series of all NIP vaccines in this study was higher than the previous similar survey conducted in 2011 in Yiwu, which estimated the coverage of NIP vaccines among migrant children to be 63.9%-70.0%. 16 The difference in immunization coverage among non-NIP vaccines may resulted from the difference in the years of introduction of the vaccine. The VarV vaccine, which was introduced in the late 1990s, has now reached a plateau of coverage of up to 74.8%, how-ever, was still lower than that of any NIP vaccine such as DTP, OPV and Hep B. The PCV7, which was in-troduced in 2008, showed a vaccination coverage of zero for a series of 3 doses scheduled at 12months, and for Hib and ORV, which was intro-duced in 2000-2002, now had coverage of up to10.4% and 27.7% for its primary vaccination, respectively. However, the coverage of Hib still remained lower compared with VarV which was introduced at a period. According to the previous studies, 17, 18 misunderstanding of the disease burden and potential effect of the vaccine might be the main reasons. People always underestimate the hazard of bacterial infections disease like Haemophilus influenza type b for abuse of antibiotics in clinical treatment in China. The lower coverage of non-NIP vaccines may also result in the accumulation of susceptible population and increase of the risk of disease resurgence consequently.
The maternal determinants identified in our study for immunization coverage of non-NIP vaccines, such as lower education level, mother with a job, mother' s poor awareness of vaccination, were in agreement with the findings of previous studies. [19] [20] [21] [22] [23] [24] [25] There were some reasons for that: first, education level may influence mother's knowledge of and attitude and behavior to take advantage of vaccination service for her child; second, mothers with jobs may not have enough time to spare for the primary healthcare including immunization, and may be less aware of the information on immunization.
Our study indicated that having more than one children, lower family income, and duration of living in the surveyed area were significant risk factors for lower uptake of non-NIP vaccines. There probably some reasons for that: first, parental attention may be diverted by the presence of multiple children in the household; second, as some non-NIP vaccines were expensive (e.g. the vaccination fee for PCV7 was approximately 133.3$), lower family income may restrict the expenses on the self-paid vaccines; third, we assumed that the migrant children with shorter duration living in the surveyed areas may face with the challenge to survive in a new environment with a higher cost of living and may have difficulties of adapting to a new sociocultural environment, while migrant children with a relative long time of www.taylorandfrancis.comliving in the surveyed area, who were familiar with the city and enjoy some social support, were better able to avail themselves of health services. 16 There has been recent recognition of pneumococcus as a prevalent pathogen responsible for the child's invasive bacterial pulmonary infection in China. Among the pathogens isolated from these infections in children aged between 3 months and 5 years, pneumococcus has replaced H. influenza as the major etiologic agent. 26 Hence, an Immunization blank of PCV7 among migrant children was alarming and the impact factors of increasing coverage of PCV7 should be monitored and explored thoroughly in China as soon as possible.
Our findings are subject to 2 limitations. First, only children with immunization record booklet were included in this study, hence, these children were already at greater probability of being vaccinated. Second, timeliness of vaccination was not con-sidered when calculating the immunization coverage and delayed vaccina-tion was considered as vaccinated, therefore, immunization cover-age for vaccines scheduled at 13-36 months may be underestimated compared to the vaccines sched-uled at 12 months of age. Despite these limitations mentioned above, our study findings may well represent a median of immunization coverage between NIP vaccines and non-NIP vaccines in Yiwu. Therefore, our study provided meaningful estimates of NIP and non-NIP vaccines that were currently used and this study would be important for immunization program managers and for immunization policy makers.
Fur-thermore, the face-to-face survey method combined with immunization record booklet data guaranteed the quality of data of this study.
In conclusion, we reported disparities of immunization coverage between NIP vaccines and non-NIP vaccines currently used in Yiwu, east China. Although coverage of non-NIP vaccines has increased over time after introduction, it is important to note that the coverage rates of non-NIP vaccines still remain lower than that of NIP vaccines. We recommend continuing monitoring on the immunization coverage for both NIP and non-NIP vaccines to assess the vulnerability to the VPDs among Chinese children. The differences of coverage described in this study may provide evidence for public health decisions on identifying susceptible population and expanding the NIP to fulfill the demands of under-vaccinated children.
Materials and Methods

Background
As a developed city in east areas in China, Yiwu has a total area of 1105.5 Km 2 with a 2 million population. Yiwu has already attracted more than 1 million migrants for its rapid social-economic development in recent years. 27 Most of these migrant people are mainly from undeveloped middle or western areas of China. Immunization clinics in Yiwu adopt the vaccination schedule recommended by the Chinese MoH, which stipulates children should vaccinate 11 NIP vaccines (22 doses)before the 7 th birthday ( Table 4) . For analysis, we selected 8 NIP vaccines, namely BCG, Hep B, OPV, DTP, MCV, Hep A, JEV, MPV-a and selected 4 non-NIP vaccines, namely VarV, Hib, ORV, PCV. The vaccnation schedule of included non-NIP vaccines were also summarized inTable 1. We excluded the MPV-ac and DT from analysis for the reason that our target children was age 1-4 y We excluded the IPV from the analysis for the reason that some children may substitute IPV for OPV and we considered these children as vaccinated. 28 The Migrants in our study refer to people living in an area without a household registration card issued by public security bureau of their current living areas. In this study, we determined the immigration status of children or their caregivers by checking their Resident ID Card or asking their residence address. Migrant children aged 1-4 years(born from 1 June 2010 to 31 May 2013) who had lived in the surveyed areas continuously for more than one month, who should to be identified and registered by the local immunization clinics, 16 were investigated. Migrant children can receive the local immunization service such as vaccination notification, immunization, health education after registration. It seems that children living in an area for a little over a month may not have had adequate time to get vaccinated, while that was not our interest in this study. Our study focused on the coverage of NIP and non-NIP vaccines for migrant children but not the performance of the immunization service system in Yiwu city. We documented the date of the last immigration to the surveyed areas of each migrant children in our interview, so we can calculate the length of time of the latest continuously living in the surveyed areas.
Sampling and data collection
The demographic data of each 13 town of Yiwu were collected by the staff of Yiwu Center for Disease Control and Prevention (CDC). Villages or communities where migrant people accounted for more than half of the total population were selected as our investigation sites. Finally, a total of 57 villages and communities were selected. The sampling procedure of this study was based on simple random sampling method. The sample size was calculated based on the following 4 parameters: a desired precision of 5% in the estimate of vaccinated children, an assumption coverage of 85%, a significance level of 0.05 and a design effect level of 2. Finally, 7 children per cluster for 57 clusters were determined as our sample size.
We got household list of each investigation site from local administrative office and used the random number to select one household as the first one to be surveyed. The target children whose immunization record booklets (green book) were available at the time of the interview were included in our study. If there was more than one target child in a household, the child whose birthday was the closest to the survey day was interviewed. After found the first eligible child, we continued choosing subsequent household located at the right of the previous one until 7 eligible children for each investigation site were interviewed.
A standardized, pretested questionnaire was used for face-toface interviews in June, 2014. The data on vaccination dates, doses, and the types of vaccine were ex-tracted from the immunization record booklets. Variables such as gender, birth status (born as preterm or full term infant), and number of siblings were collected. Maternal age, education level, the awareness and satisfaction of immunization service including family income were collected as categorical variables. Whether the child was breast milk-fed or not and past or current attendance to the daycare center was investigated for further assessing impact on coverage of non-NIP vaccines.
Definition
The immunization coverage was defined as the percentage of children who had received the recommended number of doses according to age at the surveyed time. Delayed vaccination was included in the total number of vaccinated doses. The primary series vaccination was defined as the vaccines (doses) scheduled to be given at 12 months of age.
Data analysis
To compare immunization coverage of vaccines scheduled at different age, we stratified the denominators as follows: children born from 1 June 2010 to 31 May 2013 was defined as the denominator for calculating the coverage of the vaccines scheduled at 12 months; children born from 1 June 2010 to 31 May 2012 was defined as the denominator for calculating the coverage of the vaccines scheduled at 24 months; and children born from 1 June 2010 to 31 May 2011 was defined as the denominator for calculating the coverage of the vaccines scheduled at 36 months. We also compared the immunization coverage between NIP and non-NIP vaccines. The surveyed children were also stratified into 3 cohorts to reflect birth-year-specific immunization coverage for primary series vaccination(vaccines scheduled at 12 months). These cohorts were children born We employed the single-level logistic regression model to analyze the independent variables associated with the coverage of Hib and ORV for all the surveyed children and the coverage of VarV for children born from 1 June 2010 to 31 May 2012. Each of the dependent variable was dichotomized as "immunized/not immunized" and the single-level logistic regression analysis was carried out separately. The variables with a p value <0.1 in the univariable analysis were then included in the multivariable regression using backward likelihood ratio method. The use of a more usual p value (e.g., 0.05) often fails to identify variables known to be important, while the use of a higher p value has the disadvantage of including variables that are of questionable importance. Adjusted odds ratio with 95% confidence intervals (CIs) for each variable was also calculated. The significant level was set at a p value of 0.05. All the analysis above applied Statistics Package for Social Science (SPSS) software, version 13. 0 (SPSS Inc., Chicago, IL, USA).
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